Applied Therapeutics (NASDAQ:APLT) insider Shoshana Shendelman purchased 125,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were acquired at an average price of $10.00 per share, for a total transaction of $1,250,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

NASDAQ:APLT traded down $0.01 on Monday, reaching $10.01. 73,017 shares of the company’s stock were exchanged.

COPYRIGHT VIOLATION WARNING: “Applied Therapeutics (APLT) Insider Buys $1,250,000.00 in Stock” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at

Applied Therapeutics Company Profile

Applied Therapeutics, Inc, a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy.

Read More: What is insider trading?

Receive News & Ratings for Applied Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Therapeutics and related companies with's FREE daily email newsletter.